REQUEST A DEMO
Total
USD $0.00
Search more companies

Whanin Pharmaceutical Co.,Ltd. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Whanin Pharmaceutical Co.,Ltd. Profile Updated: July 04, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Whanin Pharmaceutical Co.,Ltd. is engaged in developing, manufacturing, marketing, and selling pharmaceutical and therapeutic products. The company offers antiasthmatics, antidepressants, antipsychotics, anxiolytics & hypnotics, antiepileptics, ADHD agents, alcoholism treatment, Nootropics, antiparkinson drugs, antidementia drugs, gastrointestinal drugs, cardiovascular drugs, osteoporosis treatment, anti-inflammatory analgesics & others, urologic drugs, antibiotics, multi-vitamins, antihaemorrhoids, antidiabetic agents, respiratory drugs, antifungals, antihistamines, dermatologicals, antivirals and medical aesthetics. Whanin Pharmaceutical Co.,Ltd. is based in Seoul, South Korea. The company was incorporated in 1982.

Headquarters
84-1 Moonjung-Dong, Songpa-Gu
Seoul; Seoul; Postal Code: 138-200

Contact Details: Purchase the Whanin Pharmaceutical Co.,Ltd. report to view the information.

Website: http://www.whanin.co.kr

Basic Information
Total Employees:
Purchase the Whanin Pharmaceutical Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Whanin Pharmaceutical Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Whanin Pharmaceutical Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Whanin Pharmaceutical Co.,Ltd. report to view the information.
Incorporation Date:
December 16, 1982
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
18.63%
Purchase this report to view the information.
2.58%
Subsidiaries
앰브로비앤피(주)
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
No results were found for this company.

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?